A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) (clinicaltrials.gov) - Nov 14, 2023 - P2 | N=279 | Recruiting | Sponsor: Kezar Life Sciences, Inc. | Phase classification: P2b ➔ P2
Phase classification • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|